Mind Medicine (MindMed) Management
Management criteria checks 2/4
Mind Medicine (MindMed)'s CEO is Rob Barrow, appointed in Jun 2021, has a tenure of 3.08 years. total yearly compensation is $2.14M, comprised of 27.9% salary and 72.1% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth CA$1.73M. The average tenure of the management team and the board of directors is 2.7 years and 2.8 years respectively.
Key information
Rob Barrow
Chief executive officer
US$2.1m
Total compensation
| CEO salary percentage | 27.9% |
| CEO tenure | 3.1yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$125m |
| Dec 31 2023 | US$2m | US$599k | -US$96m |
| Sep 30 2023 | n/a | n/a | -US$77m |
| Jun 30 2023 | n/a | n/a | -US$75m |
| Mar 31 2023 | n/a | n/a | -US$63m |
| Dec 31 2022 | US$5m | US$672k | -US$57m |
| Sep 30 2022 | n/a | n/a | -US$69m |
| Jun 30 2022 | n/a | n/a | -US$69m |
| Mar 31 2022 | n/a | n/a | -US$98m |
| Dec 31 2021 | US$12m | US$350k | -US$93m |
Compensation vs Market: Rob's total compensation ($USD2.14M) is above average for companies of similar size in the Canadian market ($USD1.22M).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Barrow (35 yo)
3.1yrs
Tenure
US$2,143,133
Compensation
Mr. Robert Barrow, also known as Rob, serves as Chief Executive Officer at Mind Medicine (MindMed) Inc since June 9, 2021 and serves a its Director since December 13, 2021. He served as Chief Development O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.1yrs | US$2.14m | 0.25% CA$ 1.7m | |
| Chief Medical Officer | 3.4yrs | US$1.04m | 0.31% CA$ 2.2m | |
| Executive President | 3.9yrs | US$2.66m | 0.13% CA$ 884.7k | |
| Co-Founder & Clinical Advisor | no data | US$501.19k | no data | |
| Co-founder | no data | no data | no data | |
| VP & Chief Accounting Officer | 1.7yrs | no data | 0.048% CA$ 332.4k | |
| Chief Legal Officer & Corporate Secretary | 1.3yrs | no data | 0.045% CA$ 310.3k | |
| Chief Commercial Officer | 2.3yrs | no data | no data |
2.7yrs
Average Tenure
55.5yo
Average Age
Experienced Management: MMED's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.6yrs | US$2.14m | 0.25% CA$ 1.7m | |
| Independent Chairperson | 2.8yrs | US$196.20k | 0.018% CA$ 126.7k | |
| Independent Director | 1.1yrs | US$179.01k | 0% CA$ 0 | |
| Independent Director | 1.9yrs | US$148.70k | 0.017% CA$ 118.1k | |
| Chair of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.1yrs | no data | no data | |
| Independent Vice Chairman | 2.8yrs | US$186.20k | 0.016% CA$ 112.8k | |
| Independent Director | 1.9yrs | US$148.70k | 0.017% CA$ 118.1k | |
| Member of Scientific Advisory Board | 3.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.7yrs | no data | no data |
2.8yrs
Average Tenure
63.5yo
Average Age
Experienced Board: MMED's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/07 01:42 |
| End of Day Share Price | 2024/04/10 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mind Medicine (MindMed) Inc. is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joel Beatty | Baird |
| Sumant Satchidanand Kulkarni | Canaccord Genuity |
| Tania Armstrong-Whitworth | Canaccord Genuity |